Abstract
The value of hyperimmune gammaglobulin (HGG) therapy in ulcerative herpetic keratitis was assessed in rabbits. HGG treated of early disease in normal rabbits was very effective, producing a 10-fold rise in the virus concentration needed to infect 50% of sites (CID50) and an 88% inhibition of ulceration after 2 days. The efficacy of the gammaglobulin preparations tested depended on their anti-HSV antibody content. Established disease was considerably less responsive to HGG therapy. No conclusive effect of HGG therapy could be demonstrated in rabbits with a previous HSV skin infection ('immunised'). Corticosteroid-induced geographic ulceration in immunised rabbits was not prevented by concurrent HGG therapy. The findings indicate that HGG is unlikely to represent a useful therapy for ulcerative herpetic keratitis but that it may be valuable in primary disease and in long-term prophylaxis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amoils S. P., Maier G. Cryosurgery and immunotherapy in herpes keratitis. Br J Ophthalmol. 1973 Nov;57(11):809–814. doi: 10.1136/bjo.57.11.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carter C., Easty D. L. Experimental ulcerative herpetic keratitis. I. Systemic immune responses and resistance to corneal infection. Br J Ophthalmol. 1981 Feb;65(2):77–81. doi: 10.1136/bjo.65.2.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Easty D. Manifestations of immunodeficiency diseases in ophthalmology. Trans Ophthalmol Soc U K. 1977 Apr;97(1):8–17. [PubMed] [Google Scholar]
- KISTLER P., NITSCHMANN H. Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier. Vox Sang. 1962 Jul-Aug;7:414–424. doi: 10.1111/j.1423-0410.1962.tb03274.x. [DOI] [PubMed] [Google Scholar]
- Markham R. H., Carter C., Scobie M. A., Metcalf C., Easty D. L. Double--blind clinical trial of adenine arabinoside and idoxuridine in herpetic corneal ulcers. Trans Ophthalmol Soc U K. 1977 Jul;97(2):333–340. [PubMed] [Google Scholar]
- McClung H., Seth P., Rawls W. E. Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells. Am J Epidemiol. 1976 Aug;104(2):181–191. doi: 10.1093/oxfordjournals.aje.a112288. [DOI] [PubMed] [Google Scholar]
- Oleske J. M., Ashman R. B., Kohl S., Shore S. L., Starr S. E., Wood P., Nahmias A. J. Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells. Clin Exp Immunol. 1977 Mar;27(3):446–453. [PMC free article] [PubMed] [Google Scholar]
- Pavan P. R., Ennis F. A. The elimination of herpes simplex plaques by antibody and the emergence of resistant strains. J Immunol. 1977 Jun;118(6):2167–2175. [PubMed] [Google Scholar]
- Skinner G. R., Mushi E. Z., Whitney J. E. Immune inhibition of virus release from herpes simplex virus-infected cells. Intervirology. 1975;6(4-5):296–308. doi: 10.1159/000149483. [DOI] [PubMed] [Google Scholar]